Form 4: Life360 Director John Coghlan Reports RSU Grant and Pre-Arranged Stock Sale

Life360 Director John Coghlan reported the grant of 3,344 Restricted Stock Units and the sale of 3,125 common shares through a pre-arranged 10b5-1 trading plan.

Summary

• John Philip Coghlan, a Director of Life360, Inc. (LIF), reported transactions involving the company's common stock.
• On May 29, 2025, Mr. Coghlan was granted 3,344 Restricted Stock Units (RSUs) at a price of $0. Each RSU represents a contingent right to receive one share of common stock upon settlement.
• These RSUs will vest quarterly, with 1/4th vesting from May 15, 2025, contingent on Mr. Coghlan's continuous service.
• On June 2, 2025, Mr. Coghlan disposed of 3,125 shares of common stock through a sale.
• The shares were sold at a weighted average price of $61.03, with individual transaction prices ranging from $60.84 to $61.14.
• This sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Coghlan on December 6, 2024.
• Following these transactions, Mr. Coghlan beneficially owns 5,086 RSUs, 29,778 common shares held by the John Coghlan Living Trust, and 64,834 common shares held by The John Philip Coghlan 2024 Grantor Retained Annuity Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The RSU grant is a positive sign of continued alignment and incentive for the director. The stock sale, while a disposition, was conducted under a pre-arranged 10b5-1 plan, which mitigates negative interpretations as it implies the decision was made without current material non-public information. It's a routine insider transaction.

Positives

• The grant of 3,344 Restricted Stock Units (RSUs) to Director John Coghlan aligns his interests with shareholders, as these units vest over time, incentivizing continued service and performance.

Negatives

• Director John Coghlan sold 3,125 shares of common stock, which, while executed under a pre-arranged 10b5-1 plan, represents a reduction in his direct equity holdings.

Future Outlook

NA

Management Comments

• "The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024."
• "The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of Company stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company."

Industry Context

This Form 4 filing details routine insider transactions for a director at Life360, Inc., a company operating in the location-sharing and family safety technology sector. Such filings are common across all industries as executives and directors manage their personal equity holdings, often through pre-arranged 10b5-1 plans to avoid accusations of trading on material non-public information. The RSU grant is a standard form of equity compensation in the tech industry to incentivize long-term commitment.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with long-term shareholder value. The 10b5-1 sale is a routine transaction and generally has minimal direct impact on share price unless it's a very large volume relative to daily trading.
• Employees: No direct impact mentioned.

Next Steps

• 1/4th of the granted Restricted Stock Units (RSUs) will vest quarterly from May 15, 2025, subject to the Reporting Person's continuous service.

Key Dates

Recommendation

Keywords

Life360, LIF, SEC Form 4, Insider Trading, Stock Sale, RSU Grant, Restricted Stock Units, 10b5-1 Plan, Director Transactions, Equity Compensation